186 related articles for article (PubMed ID: 37328910)
1. Prevalence and risk factors for laminitis within the Norwegian pony breed Nordlandshest/Lyngshest.
Lykkjen S; Stenbakk LK; Holmøy IH
Acta Vet Scand; 2023 Jun; 65(1):22. PubMed ID: 37328910
[TBL] [Abstract][Full Text] [Related]
2. Identification of modifiable factors associated with owner-reported equine laminitis in Britain using a web-based cohort study approach.
Pollard D; Wylie CE; Verheyen KLP; Newton JR
BMC Vet Res; 2019 Feb; 15(1):59. PubMed ID: 30755193
[TBL] [Abstract][Full Text] [Related]
3. Incidence and clinical signs of owner-reported equine laminitis in a cohort of horses and ponies in Great Britain.
Pollard D; Wylie CE; Newton JR; Verheyen KLP
Equine Vet J; 2019 Sep; 51(5):587-594. PubMed ID: 30516850
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
Wylie CE; Collins SN; Verheyen KL; Newton JR
Vet J; 2013 Oct; 198(1):57-69. PubMed ID: 24070987
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
Karikoski NP; Horn I; McGowan TW; McGowan CM
Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
[TBL] [Abstract][Full Text] [Related]
6. Incidence of laminitis and survey of dietary and management practices in pleasure horses and ponies in south-eastern Australia.
Potter SJ; Bamford NJ; Harris PA; Bailey SR
Aust Vet J; 2017 Oct; 95(10):370-374. PubMed ID: 28948628
[TBL] [Abstract][Full Text] [Related]
7. Obesity and obesity-associated metabolic disease conditions in Connemara ponies in Ireland.
Al-Ansari AS; Golding E; Walshe N; Mooney CT; Duggan V
Equine Vet J; 2024 Mar; 56(2):273-280. PubMed ID: 37985219
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, matched case-control study of risk factors for equine laminitis.
Alford P; Geller S; Richrdson B; Slater M; Honnas C; Foreman J; Robinson J; Messer M; Roberts M; Goble D; Hood D; Chaffin M
Prev Vet Med; 2001 May; 49(3-4):209-22. PubMed ID: 11311954
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with euthanasia in horses and ponies enrolled in a laminitis cohort study in Great Britain.
Pollard D; Wylie CE; Newton JR; Verheyen KLP
Prev Vet Med; 2020 Jan; 174():104833. PubMed ID: 31751854
[TBL] [Abstract][Full Text] [Related]
10. Equine metabolic syndrome in UK native ponies and cobs is highly prevalent with modifiable risk factors.
Carslake HB; Pinchbeck GL; McGowan CM
Equine Vet J; 2021 Sep; 53(5):923-934. PubMed ID: 33128277
[TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.
Menzies-Gow NJ; Harris PA; Elliott J
Equine Vet J; 2017 May; 49(3):300-306. PubMed ID: 27363591
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
de Laat MA; Sillence MN; Reiche DB
J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
[TBL] [Abstract][Full Text] [Related]
13. Predictors of laminitis development in a cohort of nonlaminitic ponies.
Knowles EJ; Elliott J; Harris PA; Chang YM; Menzies-Gow NJ
Equine Vet J; 2023 Jan; 55(1):12-23. PubMed ID: 35263471
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profile distinguishes laminitis-susceptible and -resistant ponies before and after feeding a high sugar diet.
Delarocque J; Reiche DB; Meier AD; Warnken T; Feige K; Sillence MN
BMC Vet Res; 2021 Jan; 17(1):56. PubMed ID: 33509165
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and factors associated with development of laminitis in horses with duodenitis/proximal jejunitis: 33 cases (1985-1991).
Cohen ND; Parson EM; Seahorn TL; Carter GK
J Am Vet Med Assoc; 1994 Jan; 204(2):250-4. PubMed ID: 8144386
[TBL] [Abstract][Full Text] [Related]
16. Assessment of horse owners' ability to recognise equine laminitis: A cross-sectional study of 93 veterinary diagnosed cases in Great Britain.
Pollard D; Wylie CE; Verheyen KLP; Newton JR
Equine Vet J; 2017 Nov; 49(6):759-766. PubMed ID: 28543943
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
de Laat MA; Reiche DB; Sillence MN; McGree JM
J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
[TBL] [Abstract][Full Text] [Related]
18. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
Donaldson MT; Jorgensen AJ; Beech J
J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
